Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02899416
Other study ID # 2015_24
Secondary ID 2016-A00386-45
Status Recruiting
Phase
First received
Last updated
Start date February 23, 2017
Est. completion date March 2022

Study information

Verified date October 2021
Source University Hospital, Lille
Contact Frédéric Gottrand, MD,PhD
Phone (0)3 20 44 60 58
Email frederic.gottrand@chru-lille.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

BELINDA is a follow'up of subjects included 10 years ago in HELENA study which was a cross-sectional study carried out from 2006 to 2007 in more than 3500 adolescents aged from 12.5 to 17.5 years old through 10 Europeans towns from 9 countries. BELINDA main objective is to assess CV risk using PDAY score (Pathobiological Determinants of Atherosclerosis in Youth) during young adulthood (20 to 31 years) and analyze lifestyle risk factors from adolescence (12 to 18 years). This analyze may define new CV risk factors and risk population cluster.


Description:

BELINDA subjects from Lille, Ghent , Zaragoza and Roma will be re-tested using a part of HELENA test battery and some new evaluation criteria.


Recruitment information / eligibility

Status Recruiting
Enrollment 330
Est. completion date March 2022
Est. primary completion date March 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 35 Years
Eligibility Inclusion Criteria: - Women of men participating to HELENA study 2006-2007 - Aged from 20 to 35 years. - Signed informed consent Exclusion Criteria: - Pregnant or lactating women

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHRU,Hôpital Jeanne de Flandres Lille

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary PDAY score (Pathobiological Determinants of Atherosclerosis in Youth) PDAY score is a composite score which will be calculated using adult data including Gender, HDL non cholesterol, HDL cholesterol. Glucose level, Blood pressure, Tobacco consumption and BMI. one day
Secondary Diet Quality Index Score data collected using HELENA-DIAT, an electronic dietary recall, data in DQI score unit.
DQI score is ranking from 0 to 9 unit and is based on three basic principles for a healthy diet: quality; diversity; balance. Furthermore, the daily diet was divided into nine recommended food groups, namely (1) water, (2) bread and cereals, (3) grains and potatoes, (4) vegetables, (5) fruit, (6) milk products (7), cheese, (8) meat, fish, eggs and substitutes, and (9) fats and oils.
2 days
Secondary Ratio total energy intake data collected using HELENA-DIAT, an electronic dietary recall, data in kcal/d, data for recommended total energy intake will be collected using national reference chart. 2 days
Secondary ratio of dietary n-6/n-3 polyunsaturated fatty acids (PUFA) data collected using HELENA-DIAT, an electronic dietary recall, data in ratio calculated using a food composition data base. PUFA is expressed in mg/day daily intake. 2 days
Secondary consumption in dietary salt intake data collected using HELENA-DIAT, an electronic dietary recall, data in mg/day daily intake calculated using a food composition data base. 2 days
Secondary Physical activity data collected using a GT3X accelerometer data in daily counts/min 7 days
Secondary Endurance data collected using Dr Leger Shuttle run test, data in VO2max ml/kg/min 1 day
Secondary Ratio waist-to-hip data collected using anthropometric measurements, data in ratio. Data are expressed in centimeter 1 day
Secondary Fat mass data collected using anthropometric measurements, data in % of fat mass, expressed in kg 1 day
Secondary Education level data collected using a Socio-economic questionnaire, data in Education level 8 digits 1 day
See also
  Status Clinical Trial Phase
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04481503 - Transthoracic Echocardiography of Ventricular Function of Parturients in Labor
Terminated NCT04088240 - Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease N/A
Completed NCT03410342 - The Effects of Types of Fruits and Vegetables on Vascular Function N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Recruiting NCT04231838 - Metabolic Syndrome in Diabetic Smokers Using Cigarettes & Combustion-Free Nicotine Delivery Systems N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04562467 - The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk Phase 4
Completed NCT03429920 - Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors N/A
Completed NCT04551872 - RESILIENCE: Personalizing Cardiovascular Health N/A
Enrolling by invitation NCT03314818 - Natural History of Carotid Plaque as Determined by 3D Ultrasound N/A
Completed NCT03060811 - Mediterranean Diet, Trimethylamine N-oxide (TMAO) and Anti-oxidants in Healthy Adults N/A
Completed NCT04279704 - Overcoming Obstacles in Epigenetic Analysis of Human Twins
Completed NCT01050205 - The Healthy Lifestyle Project N/A
Completed NCT03570840 - Pediatric Metabolic Syndrome Study
Completed NCT03039023 - Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans N/A
Completed NCT03646175 - Choline Supplementation and Cardiovascular Health N/A